In a randomized clinical trial, researchers from Huntsman Cancer Institute at the University of Utah (the U) have found that ...
Researchers at Huntsman Cancer Institute have found that fewer sessions of higher dose vaginal cuff brachytherapy work just ...
12h
News Medical on MSNShort-course, higher dose vaginal brachytherapy for endometrial cancer shown to be effectiveIn a randomized clinical trial, researchers from Huntsman Cancer Institute at the University of Utah (the U) have found that short-course, higher dose vaginal brachytherapy for endometrial cancer had ...
51mon MSN
A 58-year-old woman mistook her womb cancer symptoms for menopause until her stomach became swollen. Diagnosed with ...
Endometrial cancer (EC) is the most common gynecological malignancy in developed countries, with its incidence steadily rising worldwide due to increasing ...
Your doctor may prescribe a combination of treatments for endometrial cancer, which often include chemotherapy after surgery or if surgery isn’t an option. Chemotherapy for endometrial cancer ...
In a randomized clinical trial, researchers from Huntsman Cancer Institute at the University of Utah (the U) have found that short-course, higher ...
6d
GlobalData on MSNFDA grants breakthrough designation for Acrivon’s endometrial cancer assayThe US Food and Drug Administration (FDA) has granted breakthrough device designation for Acrivon Therapeutics’ ACR-368 ...
Endometrial cancer (EC) ranks as the second most prevalent gynecologic malignancy globally, with approximately 189,000 new ...
The ACR-368-tailored OncoSignature assay is being used to predict patients most likely to respond to ACR-368 in Acrivon’s ongoing, registrational-intent, multicenter Phase 2b trial of ACR-368 in ...
A coroner found there were "missed opportunities" to treat a 38-year-old woman with cancer. Carla Smith, 38, who died on 7 ...
Uterine fibroids are non-cancerous growths that can cause heavy bleeding fatigue and pelvic pain impacting daily life While ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results